BiotechTube
Home/Pipeline/Anti-metastasis Drug Discovery

Anti-metastasis Drug Discovery

Multiple Solid Tumors

Preclinical/DiscoveryActive

Key Facts

Indication
Multiple Solid Tumors
Phase
Preclinical/Discovery
Status
Active
Company
Mestastop Solutions

About Mestastop Solutions

Mestastop Solutions develops proprietary platforms to unravel metastasis biology for drug discovery and companion diagnostics in oncology.

View full company profile

Therapeutic Areas

Oncology

Other Multiple Solid Tumors Drugs

DrugCompanyPhase
CLD-401Calidi BiotherapeuticsIND-Enabling
Abexinostat + PembrolizumabXynomic PharmaceuticalsPhase 1b
Early Cancer Detection PlatformAstrin BiosciencesPre-clinical
ABC (²¹²Pb-undisclosed)ARTBIODiscovery
UNO (Ultrahigh NO)Beyond AirPhase 1/2
SonoLeukin™VesselonPre-clinical
ELEPHAS-04 (Mayo Clinic)Elephas BiosciencesObservational
Metastasis Companion DiagnosticMestastop SolutionsProspective Clinical Trials
Zimberelimab (AB122)Arcus BiosciencesPhase 3
ORIC-101ORIC PharmaceuticalsPhase 1b
MGC026MacroGenicsPhase 1
MGC028MacroGenicsPhase 1